Konbei Stock
600572
Zhejiang Conba Pharmaceutical Co., Ltd. (600572.SH), formerly known as Lanxi Yunshan Pharmaceutical Factory, has evolved over more than five decades into a leading enterprise in the Chinese herbal medicine industry. It is now the largest such enterprise in Zhejiang Province, integrating the research, development, production, and sales of pharmaceuticals and health products. The company has been recognized as a national innovative enterprise and a "science and technology reform enterprise" by the State-owned Assets Supervision and Administration Commission of the State Council. The controlling shareholder of the company is Zhejiang Pharmaceutical and Health Industry Group Co., Ltd., a wholly-owned subsidiary of Zhejiang International Business Group Co., Ltd.
The company's headquarters is located in Hangzhou, with Zhejiang as the center for industrial development. It has established industrial bases in Jiangxi, Yunnan, Inner Mongolia, and other regions, with a total workforce exceeding 8,000 employees. The company boasts innovative platforms such as a national-level enterprise technology center, a postdoctoral research station, and a provincial key laboratory for traditional Chinese medicine pharmaceutical technology, as well as a provincial key enterprise research institute. It possesses a large brand matrix represented by well-known trademarks such as Conba, Qianliekang, Tianbaoning, and renowned brands like Jindi and Jinaokang. The company has 17 products with annual sales revenue exceeding 100 million yuan. Guided by the fundamental principle of "preserving the essence and innovating with integrity", the company focuses on the "one pillar, two sidelines" business positioning, with comprehensive traditional Chinese medicine health products as the pillar and specialty chemical drugs and specialty health consumer products as the two sidelines. At the same time, it adheres to the "three unwavering principles", unwavering in its industrial development strategy centered on the core business of comprehensive traditional Chinese medicine health products, unwavering in its "one pillar, two sidelines" product business positioning with comprehensive traditional Chinese medicine health products as the pillar, and unwavering in its product management strategy focusing on key big brands and varieties. The company focuses on core business, innovation and development, and strives to build the main platform for the traditional Chinese medicine health industry in Zhejiang Province.
In the future, the company will fully leverage the advantages of the mixed-ownership enterprise system and mechanism, intensify its efforts in the field of comprehensive traditional Chinese medicine health products, strive to achieve new breakthroughs in innovation platform construction, resource integration and development, and management quality improvement and efficiency enhancement, upgrade its competitiveness in the new development ecosystem, become an important force in building a hub of life and health science and technology innovation in our province, and make new contributions to helping our province achieve strong development in traditional Chinese medicine and high-quality development, and build a common prosperity demonstration area.
